Cyclosporine API Market Report – Research, Industry Analysis Reports and Market Demands

Global Cyclosporine API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Cyclosporine API Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Purity≥99%
- 1.3.3 Purity<99%
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Cyclosporine API Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Capsule
- 1.4.3 Tablet
- 1.4.4 Injection
- 1.4.5 Eye Drops
- 1.4.6 Others
1.5 Global Cyclosporine API Market Size & Forecast
- 1.5.1 Global Cyclosporine API Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Cyclosporine API Sales Quantity (2020-2031)
- 1.5.3 Global Cyclosporine API Average Price (2020-2031)

2 Manufacturers Profiles

3 Competitive Environment: Cyclosporine API by Manufacturer

3.1 Global Cyclosporine API Sales Quantity by Manufacturer (2020-2025)
3.2 Global Cyclosporine API Revenue by Manufacturer (2020-2025)
3.3 Global Cyclosporine API Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Cyclosporine API by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Cyclosporine API Manufacturer Market Share in 2024
- 3.4.3 Top 6 Cyclosporine API Manufacturer Market Share in 2024
3.5 Cyclosporine API Market: Overall Company Footprint Analysis
- 3.5.1 Cyclosporine API Market: Region Footprint
- 3.5.2 Cyclosporine API Market: Company Product Type Footprint
- 3.5.3 Cyclosporine API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Cyclosporine API Market Size by Region
- 4.1.1 Global Cyclosporine API Sales Quantity by Region (2020-2031)
- 4.1.2 Global Cyclosporine API Consumption Value by Region (2020-2031)
- 4.1.3 Global Cyclosporine API Average Price by Region (2020-2031)
4.2 North America Cyclosporine API Consumption Value (2020-2031)
4.3 Europe Cyclosporine API Consumption Value (2020-2031)
4.4 Asia-Pacific Cyclosporine API Consumption Value (2020-2031)
4.5 South America Cyclosporine API Consumption Value (2020-2031)
4.6 Middle East & Africa Cyclosporine API Consumption Value (2020-2031)

5 Market Segment by Type

5.1 Global Cyclosporine API Sales Quantity by Type (2020-2031)
5.2 Global Cyclosporine API Consumption Value by Type (2020-2031)
5.3 Global Cyclosporine API Average Price by Type (2020-2031)

6 Market Segment by Application

6.1 Global Cyclosporine API Sales Quantity by Application (2020-2031)
6.2 Global Cyclosporine API Consumption Value by Application (2020-2031)
6.3 Global Cyclosporine API Average Price by Application (2020-2031)

7 North America

7.1 North America Cyclosporine API Sales Quantity by Type (2020-2031)
7.2 North America Cyclosporine API Sales Quantity by Application (2020-2031)
7.3 North America Cyclosporine API Market Size by Country
- 7.3.1 North America Cyclosporine API Sales Quantity by Country (2020-2031)
- 7.3.2 North America Cyclosporine API Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

8.1 Europe Cyclosporine API Sales Quantity by Type (2020-2031)
8.2 Europe Cyclosporine API Sales Quantity by Application (2020-2031)
8.3 Europe Cyclosporine API Market Size by Country
- 8.3.1 Europe Cyclosporine API Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Cyclosporine API Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

9.1 Asia-Pacific Cyclosporine API Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Cyclosporine API Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Cyclosporine API Market Size by Region
- 9.3.1 Asia-Pacific Cyclosporine API Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Cyclosporine API Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

10.1 South America Cyclosporine API Sales Quantity by Type (2020-2031)
10.2 South America Cyclosporine API Sales Quantity by Application (2020-2031)
10.3 South America Cyclosporine API Market Size by Country
- 10.3.1 South America Cyclosporine API Sales Quantity by Country (2020-2031)
- 10.3.2 South America Cyclosporine API Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

11.1 Middle East & Africa Cyclosporine API Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Cyclosporine API Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Cyclosporine API Market Size by Country
- 11.3.1 Middle East & Africa Cyclosporine API Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Cyclosporine API Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

12.1 Cyclosporine API Market Drivers
12.2 Cyclosporine API Market Restraints
12.3 Cyclosporine API Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Cyclosporine API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cyclosporine API
13.3 Cyclosporine API Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Cyclosporine API Typical Distributors
14.3 Cyclosporine API Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Cyclosporine API market size was valued at US$ 95.7 million in 2024 and is forecast to a readjusted size of USD 122 million by 2031 with a CAGR of 3.4% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Cyclosporine API is an active pharmaceutical ingredient that belongs to the class of cyclic polypeptide macrolides. It was originally derived from the soil fungus Tolypocladium inflatum. Also known as Cyclosporine A, it was discovered by Sandoz and developed for the treatment of immune disorders. Its primary mechanism of action is to inhibit T - lymphocyte function. Upon administration, Cyclosporine API binds to cyclophilin A, thereby inhibiting calcineurin and leading to the suppression of the immune system. It is widely used in the prevention of transplant rejections, as well as in the treatment of diseases such as rheumatoid arthritis, psoriasis, and keratoconjunctivitis sicca.
The Cyclosporine API industry is currently on a path of stable growth and is expected to maintain this trend in the coming years. Driven by its extensive applications in organ transplantation, autoimmune disorders, and other therapeutic areas, the market demand for Cyclosporine API is increasing. The growing prevalence of chronic diseases and the aging population have also contributed to the rising demand for immunosuppressant therapies like cyclosporine. Advancements in pharmaceutical manufacturing technologies have optimized the production processes of Cyclosporine API, improving yield and operational efficiencies. Meanwhile, the rising approval of generics and biosimilars is expected to enhance market dynamics, making treatments more accessible and affordable. In addition, ongoing clinical trials and research into new delivery mechanisms will further promote the evolution of the Cyclosporine API market. The focus on personalized medicine and the development of combination therapies are also important trends shaping the future of this market. Regionally, North America is a leading market due to its advanced technology infrastructure, high consumer demand, and significant R&D investment, while the Asia - Pacific region is growing rapidly, driven by factors such as population growth, urbanization, and rising disposable incomes. Moreover, with the increasing emphasis on sustainability and environmentally friendly production practices, the Cyclosporine API industry may also witness changes in sourcing and manufacturing strategies in the future.
This report is a detailed and comprehensive analysis for global Cyclosporine API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cyclosporine API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Cyclosporine API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Cyclosporine API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Cyclosporine API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cyclosporine API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cyclosporine API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Curia Global, Inc., Concord Biotech, Chemwerth Inc, Ckd Bio Corporation, Octagonchem, Manus Aktteva Biopharma LLP, Fishfa Biogenics, Novas International, Guangzhou Tosun Pharmaceutical Ltd, Ruibang, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cyclosporine API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥99%
Purity<99%
Market segment by Application
Capsule
Tablet
Injection
Eye Drops
Others
Major players covered
Curia Global, Inc.
Concord Biotech
Chemwerth Inc
Ckd Bio Corporation
Octagonchem
Manus Aktteva Biopharma LLP
Fishfa Biogenics
Novas International
Guangzhou Tosun Pharmaceutical Ltd
Ruibang
Medisca
Fujian Kerui Pharmaceutical Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cyclosporine API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cyclosporine API, with price, sales quantity, revenue, and global market share of Cyclosporine API from 2020 to 2025.
Chapter 3, the Cyclosporine API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cyclosporine API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Cyclosporine API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cyclosporine API.
Chapter 14 and 15, to describe Cyclosporine API sales channel, distributors, customers, research findings and conclusion.

Buy now